Browse > Article
http://dx.doi.org/10.5483/BMBRep.2015.48.4.007

MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis  

Hur, Keun (Department of Biochemistry and Cell Biology, Cell and Matrix Research Institute, School of Medicine, Kyungpook National University)
Publication Information
BMB Reports / v.48, no.4, 2015 , pp. 217-222 More about this Journal
Abstract
Colorectal cancer (CRC) is the third most common cancer and the fourth most common cause of cancer-related death worldwide. Distant metastasis is a major cause of mortality in CRC. MicroRNAs (miRNAs) are small non-coding RNA molecules involved in the post-transcriptional and translational regulation of gene expression. Many miRNAs are aberrantly expressed in cancer and influence tumor progression. Accumulating studies suggest that multiple miRNAs are actively involved in the CRC metastasis process. Thus, we aim to introduce the role of miRNAs in multi-steps of CRC metastasis, including cancer cell invasion, intravasation, circulation, extravasation, colonization, angiogenesis, and epithelial-mesenchymal transition (EMT). Moreover, we suggest the potential application of miRNAs as biomarkers for CRC patients with metastasis. [BMB Reports 2015; 48(4): 217-222]
Keywords
Biomarker; Colorectal cancer; Metastasis; MicroRNA;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62   DOI   ScienceOn
2 Poliseno L, Tuccoli A, Mariani L et al (2006) MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108, 3068-3071   DOI   ScienceOn
3 Xu Q, Liu LZ, Qian X et al (2012) MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res 40, 761-774   DOI
4 Guo ST, Jiang CC, Wang GP et al (2013) MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. Oncogene 32, 1910-1920   DOI   ScienceOn
5 Sundaram P, Hultine S, Smith LM et al (2011) p53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers. Cancer Res 71, 7490-7501   DOI
6 Dews M, Homayouni A, Yu D et al (2006) Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38, 1060-1065   DOI   ScienceOn
7 Kalluri R and Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119, 1420-1428   DOI   ScienceOn
8 Thiery JP, Acloque H, Huang RY and Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890   DOI   ScienceOn
9 Burk U, Schubert J, Wellner U et al (2008) A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9, 582-589   DOI   ScienceOn
10 Gregory PA, Bracken CP, Smith E et al (2011) An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell 22, 1686-1698   DOI
11 Gregory PA, Bert AG, Paterson EL et al (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10, 593-601   DOI   ScienceOn
12 Park SM, Gaur AB, Lengyel E and Peter ME (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22, 894-907   DOI   ScienceOn
13 Hur K, Toiyama Y, Takahashi M et al (2013) MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut 62, 1315-1326   DOI   ScienceOn
14 Rokavec M, Oner MG, Li H et al (2014) IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. J Clin Invest 124, 1853-1867   DOI   ScienceOn
15 Booth RA (2007) Minimally invasive biomarkers for detection and staging of colorectal cancer. Cancer Lett 249, 87-96   DOI   ScienceOn
16 Habermann JK, Bader FG, Franke C et al (2008) From the genome to the proteome--biomarkers in colorectal cancer. Langenbecks Arch Surg 393, 93-104   DOI
17 Soreide K, Nedrebo BS, Knapp JC, Glomsaker TB, Soreide JA and Korner H (2009) Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist. Surg Oncol 18, 31-50   DOI   ScienceOn
18 Duffy MJ (2001) Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 47, 624-630
19 Toiyama Y, Takahashi M, Hur K et al (2013) Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J Natl Cancer Inst 105, 849-859   DOI   ScienceOn
20 Mandel JS, Bond JH, Church TR et al (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328, 1365-1371   DOI   ScienceOn
21 Kanaan Z, Roberts H, Eichenberger MR et al (2013) A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Ann Surg 258, 400-408   DOI   ScienceOn
22 Wang S, Xiang J, Li Z et al (2015) A plasma microRNA panel for early detection of colorectal cancer. Int J Cancer 136, 152-161   DOI   ScienceOn
23 Toiyama Y, Hur K, Tanaka K et al (2014) Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Ann Surg 259, 735-743   DOI
24 Hur K, Toiyama Y, Schetter AJ et al (2015) Identification of a Metastasis-Specific MicroRNA Signature in Human Colorectal Cancer. J Natl Cancer Inst 107   DOI   ScienceOn
25 Wang CJ, Stratmann J, Zhou ZG and Sun XF (2010) Suppression of microRNA-31 increases sensitivity to 5-FU at an early stage, and affects cell migration and invasion in HCT-116 colon cancer cells. BMC Cancer 10, 616   DOI   ScienceOn
26 Akao Y, Noguchi S, Iio A, Kojima K, Takagi T and Naoe T (2011) Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. Cancer Lett 300, 197-204   DOI   ScienceOn
27 Nakagawa Y, Iinuma M, Naoe T, Nozawa Y and Akao Y (2007) Characterized mechanism of alpha-mangostin-induced cell death: caspase-independent apoptosis with release of endonuclease-G from mitochondria and increased miR-143 expression in human colorectal cancer DLD-1 cells. Bioorg Med Chem 15, 5620-5628   DOI   ScienceOn
28 Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233   DOI   ScienceOn
29 Ng EK, Tsang WP, Ng SS et al (2009) MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101, 699-706   DOI   ScienceOn
30 Friedman JM and Jones PA (2009) MicroRNAs: critical mediators of differentiation, development and disease. Swiss Med Wkly 139, 466-472
31 Kim VN, Han J and Siomi MC (2009) Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 10, 126-139   DOI   ScienceOn
32 Siegel R, Desantis C and Jemal A (2014) Colorectal cancer statistics, 2014. CA Cancer J Clin 64, 104-117   DOI   ScienceOn
33 Chang TC, Wentzel EA, Kent OA et al (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26, 745-752   DOI   ScienceOn
34 Kopetz S, Chang GJ, Overman MJ et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27, 3677-3683   DOI   ScienceOn
35 Rees M, Tekkis PP, Welsh FK, O'Rourke T and John TG (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247, 125-135   DOI   ScienceOn
36 Nagel R, le Sage C, Diosdado B et al (2008) Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 68, 5795-5802   DOI   ScienceOn
37 Diosdado B, van de Wiel MA, Terhaar Sive Droste JS et al (2009) MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 101, 707-714   DOI   ScienceOn
38 Chen X, Guo X, Zhang H et al (2009) Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28, 1385-1392   DOI   ScienceOn
39 Guo C, Sah JF, Beard L, Willson JK, Markowitz SD and Guda K (2008) The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 47, 939-946   DOI   ScienceOn
40 Krichevsky AM and Gabriely G (2009) miR-21: a small multi-faceted RNA. J Cell Mol Med 13, 39-53   DOI   ScienceOn
41 Akao Y, Nakagawa Y and Naoe T (2006) let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29, 903-906   DOI   ScienceOn
42 Asangani IA, Rasheed SA, Nikolova DA et al (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136   DOI   ScienceOn
43 Tsang WP and Kwok TT (2009) The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras. Carcinogenesis 30, 953-959   DOI   ScienceOn
44 Hanahan D and Weinberg RA (2000) The hallmarks of cancer. Cell 100, 57-70   DOI   ScienceOn
45 Friedl P and Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3, 362-374   DOI   ScienceOn
46 Volinia S, Calin GA, Liu CG et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103, 2257-2261   DOI   ScienceOn
47 Sayed D, Rane S, Lypowy J et al (2008) MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 19, 3272-3282   DOI   ScienceOn
48 Zhu S, Si ML, Wu H and Mo YY (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282, 14328-14336   DOI   ScienceOn
49 Gabriely G, Wurdinger T, Kesari S et al (2008) MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28, 5369-5380   DOI   ScienceOn
50 Vicinus B, Rubie C, Faust SK et al (2012) miR-21 functionally interacts with the 3'UTR of chemokine CCL20 and down-regulates CCL20 expression in miR-21 transfected colorectal cancer cells. Cancer Lett 316, 105-112   DOI   ScienceOn
51 Wang P, Zou F, Zhang X et al (2009) microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 69, 8157-8165   DOI   ScienceOn
52 Cottonham CL, Kaneko S and Xu L (2010) miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells. J Biol Chem 285, 35293-35302   DOI   ScienceOn
53 Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST and Patel T (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658   DOI   ScienceOn
54 Slaby O, Svoboda M, Fabian P et al (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72, 397-402   DOI   ScienceOn
55 Faltejskova P, Besse A, Sevcikova S et al (2012) Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells. Int J Colorectal Dis 27, 1401-1408   DOI   ScienceOn
56 Chen HY, Lin YM, Chung HC et al (2012) miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res 72, 3631-3641   DOI   ScienceOn
57 Fu J, Tang W, Du P et al (2012) Identifying microRNAmRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis. BMC Syst Biol 6, 68   DOI
58 Harris TA, Yamakuchi M, Ferlito M, Mendell JT and Lowenstein CJ (2008) MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A 105, 1516-1521   DOI   ScienceOn
59 Huang Z, Huang D, Ni S, Peng Z, Sheng W and Du X (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127, 118-126   DOI   ScienceOn
60 Kanaan Z, Rai SN, Eichenberger MR et al (2012) Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer. Hum Mutat 33, 551-560   DOI   ScienceOn
61 Vickers MM, Bar J, Gorn-Hondermann I et al (2012) Stagedependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clin Exp Metastasis 29, 123-132   DOI   ScienceOn
62 Lu LF and Liston A (2009) MicroRNA in the immune system, microRNA as an immune system. Immunology 127, 291-298   DOI   ScienceOn
63 Bu P, Chen KY, Chen JH et al (2013) A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell 12, 602-615   DOI   ScienceOn
64 Hwang WL, Jiang JK, Yang SH et al (2014) MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol 16, 268-280   DOI   ScienceOn
65 Bitarte N, Bandres E, Boni V et al (2011) MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells 29, 1661-1671   DOI   ScienceOn
66 Fang Y, Gu X, Li Z, Xiang J and Chen Z (2013) miR-449b inhibits the proliferation of SW1116 colon cancer stem cells through downregulation of CCND1 and E2F3 expression. Oncol Rep 30, 399-406   DOI
67 Bonauer A, Carmona G, Iwasaki M et al (2009) Micro-RNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324, 1710-1713   DOI   ScienceOn
68 Yamakuchi M, Lotterman CD, Bao C et al (2010) P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci U S A 107, 6334-6339   DOI   ScienceOn
69 Heldin CH, Vanlandewijck M and Moustakas A (2012) Regulation of EMT by TGFbeta in cancer. FEBS Lett 586, 1959-1970   DOI   ScienceOn